{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:59:53Z","timestamp":1778662793010,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005713","name":"Office of the Secretary of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0159"],"award-info":[{"award-number":["W81XWH-15-1-0159"]}],"id":[{"id":"10.13039\/100005713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR053503"],"award-info":[{"award-number":["AR053503"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR070254"],"award-info":[{"award-number":["AR070254"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015629","name":"Jerome L. Greene Foundation","doi-asserted-by":"crossref","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015629","name":"Jerome L. Greene Foundation","doi-asserted-by":"crossref","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Camille Julia Morgan Arthritis Research and Education Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1533-z","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T23:25:45Z","timestamp":1521761145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Laura C.","family":"Cappelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian F.","family":"Konig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan C.","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Clifton O.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"issue":"10","key":"1533_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2012.134","volume":"8","author":"WP Arend","year":"2012","unstructured":"Arend WP, Firestein GS. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol. 2012;8(10):573\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1533_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/rheumatology\/keu323","volume":"55","author":"A Yarwood","year":"2016","unstructured":"Yarwood A, Huizinga TW, Worthington J. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. Rheumatology (Oxford). 2016;55(2):199\u2013209.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1533_CR3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","volume":"65","author":"VC Willis","year":"2013","unstructured":"Willis VC, Demoruelle MK, Derber LA, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 2013;65(10):2545\u201354.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1533_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/jre.12002","volume":"48","author":"GP Harvey","year":"2013","unstructured":"Harvey GP, Fitzsimmons TR, Dhamarpatni AA, et al. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res. 2013;48(2):252\u201361.","journal-title":"J Periodontal Res"},{"issue":"1","key":"1533_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1533_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/rheumatology\/kex048","volume":"56","author":"M Traylor","year":"2017","unstructured":"Traylor M, Curtis C, Patel H, et al. Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: the GENRA case-control study. Rheumatology (Oxford). 2017;56(8):1282\u201392.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1533_CR7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1136\/annrheumdis-2016-209991","volume":"76","author":"A van Zanten","year":"2017","unstructured":"van Zanten A, Arends S, Roozendaal C, et al. Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. Ann Rheum Dis. 2017;76(7):1184\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1533_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13075-016-1014-1","volume":"18","author":"K Roos","year":"2016","unstructured":"Roos K, Martinsson K, Ziegelasch M, et al. Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking. Arthritis Res Ther. 2016;18(1):119.","journal-title":"Arthritis Res Ther"},{"key":"1533_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13075-015-0638-x","volume":"17","author":"H Kokkonen","year":"2015","unstructured":"Kokkonen H, Brink M, Hansson M, et al. Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis. Arthritis Res Ther. 2015;17:125.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1533_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2005.041079","volume":"65","author":"SP Linn-Rasker","year":"2006","unstructured":"Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis. 2006;65(3):366\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1533_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38\u201346.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1533_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30(11):1205\u201313.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1533_CR13","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","volume":"34","author":"JF Restrepo","year":"2015","unstructured":"Restrepo JF, del Rincon I, Battafarano DF, et al. Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol. 2015;34(9):1529\u201336.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"1533_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/thoraxjnl-2016-208932","volume":"71","author":"EJ Bernstein","year":"2016","unstructured":"Bernstein EJ, Barr RG, Austin JHM, et al. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2016;71(12):1082\u201390.","journal-title":"Thorax"},{"issue":"3","key":"1533_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/art.10174","volume":"46","author":"DL Mattey","year":"2002","unstructured":"Mattey DL, Hutchinson D, Dawes PT, et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum. 2002;46(3):640\u20136.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1533_CR16","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/rheumatology\/kew285","volume":"55","author":"J Sokolove","year":"2016","unstructured":"Sokolove J, Wagner CA, Lahey LJ, et al. Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans. Rheumatology (Oxford). 2016;55(11):1969\u201377.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1533_CR17","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.23618","volume":"58","author":"A Kinloch","year":"2008","unstructured":"Kinloch A, Lundberg K, Wait R, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 2008;58(8):2287\u201395.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1533_CR18","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1002\/art.22983","volume":"56","author":"C Foulquier","year":"2007","unstructured":"Foulquier C, Sebbag M, Clavel C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 2007;56(11):3541\u201353.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1533_CR19","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/art.23596","volume":"58","author":"ML Harris","year":"2008","unstructured":"Harris ML, Darrah E, Lam GK, et al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum. 2008;58(7):1958\u201367.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1533_CR20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3899\/jrheum.130293","volume":"40","author":"ED Ferucci","year":"2013","unstructured":"Ferucci ED, Darrah E, Smolik I, et al. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations. J Rheumatol. 2013;40(9):1523\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"1533_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2007.080267","volume":"67","author":"EH Halvorsen","year":"2008","unstructured":"Halvorsen EH, Pollmann S, Gilboe IM, et al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis. 2008;67(3):414\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1533_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2017-211489","volume":"77","author":"J Shi","year":"2018","unstructured":"Shi J, Darrah E, Sims GP, et al. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis. Ann Rheum Dis. 2018;77(1):141\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"186","key":"1533_CR23","doi-asserted-by":"publisher","first-page":"186ra65","DOI":"10.1126\/scitranslmed.3005370","volume":"5","author":"E Darrah","year":"2013","unstructured":"Darrah E, Giles JT, Ols ML, et al. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci Transl Med. 2013;5(186):186ra65.","journal-title":"Sci Transl Med"},{"issue":"6","key":"1533_CR24","doi-asserted-by":"publisher","first-page":"e98794","DOI":"10.1371\/journal.pone.0098794","volume":"9","author":"JT Giles","year":"2014","unstructured":"Giles JT, Darrah E, Danoff S, et al. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease. PLoS One. 2014;9(6):e98794.","journal-title":"PLoS One"},{"issue":"1","key":"1533_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-016-1126-7","volume":"18","author":"I Navarro-Millan","year":"2016","unstructured":"Navarro-Millan I, Darrah E, Westfall AO, et al. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans. Arthritis Res Ther. 2016;18(1):241.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1533_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/ard.2008.094490","volume":"68","author":"EH Halvorsen","year":"2009","unstructured":"Halvorsen EH, Haavardsholm EA, Pollmann S, et al. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis. 2009;68(2):249\u201352.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1533_CR27","first-page":"969","volume":"35","author":"J Zhao","year":"2008","unstructured":"Zhao J, Zhao Y, He J, et al. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol. 2008;35(6):969\u201374.","journal-title":"J Rheumatol"},{"issue":"7","key":"1533_CR28","doi-asserted-by":"publisher","first-page":"e0180655","DOI":"10.1371\/journal.pone.0180655","volume":"12","author":"D Murphy","year":"2017","unstructured":"Murphy D, Mattey D, Hutchinson D. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se. PLoS One. 2017;12(7):e0180655.","journal-title":"PLoS One"},{"issue":"4","key":"1533_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/annrheumdis-2012-202535","volume":"73","author":"BA Fisher","year":"2014","unstructured":"Fisher BA, Bang SY, Chowdhury M, et al. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease. Ann Rheum Dis. 2014;73(4):741\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1533_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cei.12901","volume":"188","author":"K Martinsson","year":"2017","unstructured":"Martinsson K, Johansson A, Kastbom A, et al. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project). Clin Exp Immunol. 2017;188(1):53\u201362.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"1533_CR31","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/art.39118","volume":"67","author":"R Seror","year":"2015","unstructured":"Seror R, Le Gall-David S, Bonnaure-Mallet M, et al. Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis. Arthritis Rheumatol (Hoboken, NJ). 2015;67(7):1729\u201337.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"369","key":"1533_CR32","doi-asserted-by":"publisher","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","volume":"8","author":"MF Konig","year":"2016","unstructured":"Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med. 2016;8(369):369ra176.","journal-title":"Sci Transl Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1533-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:58:23Z","timestamp":1719903503000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1533-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1533-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Johns Hopkins Institutional Review Board has approved this study and all participants signed informed consent forms (IRB #: NA-00040493; NA-00071923).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ED previously served on the scientific advisory board for Padlock Therapeutics, Inc., and is an author on licensed Patent No. 8,975,033 entitled \u201cHuman Autoantibodies Specific for PAD3 which are Cross-reactive with PAD4 and their Use in the Diagnosis and Treatment of Rheumatoid Arthritis and Related Diseases\u201d. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"59"}}